GPER-mediated proliferation and estradiol production in breast cancer-associated fibroblasts

The Correlation between GPR30 and Clinicopathologic Variables in Breast Carcinomas

(2014) Gang Tu et al.   TECHNOLOGY IN CANCER RESEARCH & TREATMENT

A High-Content, Live-Cell, and Real-Time Approach to the Quantitation of Ligand-Induced β-Arrestin2 and Class A/Class B GPCR Mobilization

(2013) Anthony P. Leonard et al.   MICROSCOPY AND MICROANALYSIS

Bisphenol A Induces Gene Expression Changes and Proliferative Effects through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts

(2012) Marco Pupo et al.   ENVIRONMENTAL HEALTH PERSPECTIVES

MiRNA expression analysis of cancer-associated fibroblasts and normal fibroblasts in breast cancer

(2012) Liuyang Zhao et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

The prognostic significance of tumor-associated stroma in invasive breast carcinoma

(2012) Soomin Ahn et al.   TUMOR BIOLOGY

G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer

(2011) Atanas Ignatov et al.   BREAST CANCER RESEARCH AND TREATMENT

GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells

(2011) Adele Vivacqua et al.   BREAST CANCER RESEARCH AND TREATMENT

Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression

(2011) Paolo Cirri et al.   CANCER AND METASTASIS REVIEWS

Podoplanin-Positive Fibroblasts Enhance Lung Adenocarcinoma Tumor Formation: Podoplanin in Fibroblast Functions for Tumor Progression

(2011) A. Hoshino et al.   CANCER RESEARCH

The G-protein-coupled estrogen receptor GPER in health and disease

(2011) Eric R. Prossnitz et al.   Nature Reviews Endocrinology

Genistein induces breast cancer-associated aromatase and stimulates estrogen-dependent tumor cell growth in in vitro breast cancer model

(2011) M.B.M. van Duursen et al.   TOXICOLOGY

Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients

(2010) Esther M. de Kruijf et al.   BREAST CANCER RESEARCH AND TREATMENT

Nuclear Alternate Estrogen Receptor GPR30 Mediates 17 -Estradiol-Induced Gene Expression and Migration in Breast Cancer-Associated Fibroblasts

(2010) A. Madeo et al.   CANCER RESEARCH

The Canonical NF- B Pathway Governs Mammary Tumorigenesis in Transgenic Mice and Tumor Stem Cell Expansion

(2010) M. Liu et al.   CANCER RESEARCH

Label-free whole-cell assays: expanding the scope of GPCR screening

(2010) Clay W Scott et al.   DRUG DISCOVERY TODAY

Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells

(2009) Atanas Ignatov et al.   BREAST CANCER RESEARCH AND TREATMENT

GPR30 and estrogen receptor expression: new insights into hormone dependence of inflammatory breast cancer

(2009) Hugo Arias-Pulido et al.   BREAST CANCER RESEARCH AND TREATMENT

Stimulating the GPR30 Estrogen Receptor with a Novel Tamoxifen Analogue Activates SF-1 and Promotes Endometrial Cell Proliferation

(2009) Benjamin C. Lin et al.   CANCER RESEARCH

Estrogen-Related Cancer Microenvironment of Breast Carcinoma

(2009) Yuri YAMAGUCHI et al.   ENDOCRINE JOURNAL

Cancer associated fibroblasts (CAFs) in tumor microenvironment

(2009) Fei Xing   Frontiers in Bioscience-Landmark

Mechanisms of estrogen signaling and gene expression via GPR30

(2009) Eric R. Prossnitz et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

G Protein-Coupled Receptor 30 Expression Is Up-Regulated by EGF and TGFα in Estrogen Receptor α-Positive Cancer Cells

(2009) Adele Vivacqua et al.   MOLECULAR ENDOCRINOLOGY

Stroma in breast development and disease

(2009) Lisa M. Arendt et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY

Regulation of In Situ to Invasive Breast Carcinoma Transition

(2008) Min Hu et al.   CANCER CELL